Moraxella catarrhalis is a strict human pathogen that causes otitis media in children and exacerbations of chronic obstructive pulmonary disease in adults, resulting in significant worldwide morbidity and mortality. M. catarrhalis has a growth requirement for arginine; thus, acquiring arginine is important for fitness and survival. M. catarrhalis has a putative oligopeptide permease ABC transport operon (opp) consisting of five genes (oppB, oppC, oppD, oppF, and oppA), encoding two permeases, two ATPases, and a substrate binding protein. Thermal shift assays showed that the purified recombinant substrate binding protein OppA binds to peptides 3 to 16 amino acid residues in length regardless of the amino acid composition. A mutant in which the oppBCDFA gene cluster is knocked out showed impaired growth in minimal medium where the only source of arginine came from a peptide 5 to 10 amino acid residues in length. Whether methylated arginine supports growth of M. catarrhalis is important in understanding fitness in the respiratory tract because methylated arginine is abundant in host tissues. No growth of wildtype M. catarrhalis was observed in minimal medium in which arginine was present only in methylated form, indicating that the bacterium requires L-arginine. An oppA knockout mutant showed marked impairment in its capacity to persist in the respiratory tract compared to the wild type in a mouse pulmonary clearance model. We conclude that the Opp system mediates both uptake of peptides and fitness in the respiratory tract.
Moraxella catarrhalis, a Gram-negative diplococcus, is a commensal of the upper respiratory tract, as well as a humanspecific pathogen responsible for 10 to 20% of otitis media in children and approximately 10% of exacerbations of chronic obstructive pulmonary disease (COPD) in adults in the United States (1-6). Otitis media is the most common reason for pediatric office visits and the prescribing of antibiotics to children, typically by the age of 3 years (7-12). COPD is the third leading cause of death in the United States, affecting at least 24 million people, and costs $50 billion in health care expenses each year (13-16). COPD is considered a major unmet medical need that is increasing in prevalence throughout the world (17, 18). Antibiotic resistance is an additional concern, with nearly 100% of clinical isolates of M. catarrhalis displaying resistance to -lactam drugs with the ability to protect other -lactam-sensitive bacteria in the surrounding environment (3, 9, 19-23).In the last 2 decades, M. catarrhalis has transitioned from being considered an emerging to an established pathogen. Since this bacterium was previously considered to be a commensal, the literature on mechanisms that allow M. catarrhalis to thrive in the harsh environment of the human respiratory tract is sparse, and the associated virulence mechanisms are not well studied (1, 2, 24-29). There is a need to understand bacterial physiology and metabolism during infection as these pathways and traits could be exploited f...